When administering Lithium, key nursing considerations include monitoring patient status, checking critical laboratory values, and providing appropriate safety education. Unsafe practices such as stopping medications abruptly or doubling missed doses are incorrect.
深入解析
為何選2
Warfarin阻斷新合成vitamin K依賴因子(II·VII·IX·X)·protein C/S·已有因子消失·INR達治療範圍需5~7日。Warm-up期protein C(抗凝)較因子II下降快·暫時procoagulant·須parenteral overlap。
標準過渡(CHEST/ACC)
• Day 1 warfarin與parenteral(UFH·LMWH·fondaparinux)同時起。
• ≥5日+INR ≥2.0持續24小時以上才停parenteral。
• 之後parenteral停·warfarin單獨。
• 機械瓣·大血栓量·惡性腫瘤parenteral更長。
誤答分析
1:明天停無保護。3:停warfarin繼續enoxaparin違背長期口服計畫。4:延遲warfarin錯誤·同時起後overlap才標準。